Bill > HB781

This bill creates new provisions for the 340B drug program in Missouri, establishing guidelines for how covered entities must handle 340B drug proceeds. Specifically, the bill defines key terms such as "340B drug" (a medication obtained through a specific federal drug pricing program), "covered entity" (a healthcare organization participating in the program), and "vulnerable patient" (an uninsured individual with income at or below 400% of the federal poverty level). The legislation requires covered entities to use all 340B drug proceeds to either offset out-of-pocket costs for vulnerable patients or provide direct patient care to them. Covered entities must submit an annual certification to the state Department of Health and Senior Services, detailing the total amount of 340B drug proceeds and providing an itemized summary of how those proceeds were used. The department is empowered to investigate violations, with potential consequences including disciplinary action, license suspension, or revocation, and loss of eligibility for public funds. The bill also mandates that the department submit an annual report to state legislative leadership summarizing the program's implementation, while protecting proprietary information. The department is authorized to create rules for implementing these provisions, with specific guidelines to ensure regulatory compliance.

https://house.mo.gov/Bill.aspx?bill=HB781&year=2025&code=R